GAIN Trial: Phase 2/3 Study of COR388 in Subjects With Alzheimer's Disease

Clinical trial NCT03823404 · COMPLETED

Trial details

NCT number: NCT03823404
Sponsor: Cortexyme Inc.
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2019-03-28
Primary completion: 2022-01-01
Enrollment: 643

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.